Alternatively, by formulating melanoma-associated antigen mRNA to target the DC phagocytosis antigen uptake receptor DEC-205 through fusion to an anti-DEC-205scFv antibody region, Birkholz et al. significantly increased MHC class II presentation compared to peptide pulsing or mRNA electroporation [129]. Here, HLA-C is linked to melanoma.